Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80,899Revenue $M6,932Net Margin (%)26.9Z-Score16.5
Enterprise Value $M79,919EPS $7.8Operating Margin %36.3F-Score8
P/E(ttm))38.3Cash Flow Per Share $7.4Pre-tax Margin (%)35.8Higher ROA y-yY
Price/Book8.510-y EBITDA Growth Rate %25.7Quick Ratio1.7Cash flow > EarningsY
Price/Sales9.75-y EBITDA Growth Rate %20.1Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %43.7ROA % (ttm)15.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)21.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M237ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 342.5814%Add 41.76%8,632
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 342.5814%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 342.5814%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 342.5814%Sold Out0
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 342.588%New holding, 7500 sh.7,500
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 342.588%New holding, 3931 sh.3,931
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 342.588%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 342.588%New holding, 783 sh.783
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 342.589%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 342.588%Sold Out0
BIIBRay Dalio 2013-12-31 Add0.03%$223.85 - $295.88
($258.53)
$ 342.5832%Add 208.67%19,057
BIIBJohn Hussman 2013-12-31 Sold Out -0.99%$223.85 - $295.88
($258.53)
$ 342.5832%Sold Out0
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 342.5832%Reduce -39.09%884,000
BIIBJohn Hussman 2013-09-30 Add0.33%$206.53 - $248.13
($223.63)
$ 342.5853%Add 50%75,000
BIIBMario Gabelli 2013-09-30 Add$206.53 - $248.13
($223.63)
$ 342.5853%Add 81.87%3,310
BIIBRay Dalio 2013-09-30 Reduce-0.01%$206.53 - $248.13
($223.63)
$ 342.5853%Reduce -41.27%6,174
BIIBFrank Sands 2013-06-30 Add0.71%$192.77 - $240.86
($213.68)
$ 342.5860%Add 27.6%4,565,921
BIIBMario Gabelli 2013-06-30 Reduce$192.77 - $240.86
($213.68)
$ 342.5860%Reduce -25.1%1,820
BIIBJohn Hussman 2013-06-30 Reduce-1.45%$192.77 - $240.86
($213.68)
$ 342.5860%Reduce -80.62%50,000
BIIBPRIMECAP Management 2013-06-30 Reduce-0.28%$192.77 - $240.86
($213.68)
$ 342.5860%Reduce -5%18,246,809
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ron Baron 2014-06-308,63200.01+41.76%
BIIB Mario Gabelli 2014-06-304,17500.01+16.46%
BIIB Frank Sands 2014-06-304,891,4632.063.9+0.38%
BIIB PRIMECAP Management 2014-06-3017,258,3117.286-1.39%
BIIB Vanguard Health Care Fund 2014-06-30559,7000.240.47-6.62%
BIIB George Soros 2014-06-30000Sold Out
BIIB Joel Greenblatt 2014-06-30000Sold Out
BIIB John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.933.81view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.3710.64view
Posner Brian SDirector 2014-06-20Sell605$3159.72view
Posner Brian SDirector 2014-06-13Sell700$310.511.31view
SCANGOS GEORGE ACEO 2014-06-02Sell484$318.938.37view
Holtzman Steven HEVP Corporate Development 2014-05-19Sell1,221$289.1519.53view
SCANGOS GEORGE ACEO 2014-05-01Sell2,123$285.5621.03view
Holtzman Steven HEVP Corporate Development 2014-04-17Sell1,221$29118.77view
PANGIA ROBERT WDirector 2014-04-01Sell6,250$308.4212.06view
SCANGOS GEORGE ACEO 2014-04-01Sell2,123$308.4212.06view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
    Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
    PRIMECAP Trims Top Biotechs and More Aug 30 2013 
    Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
    52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE Sep 24 2012 
    Weekly Top Insider Sells: GOOG, FIS, ORCL, and BIIB Aug 06 2012 
    Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
    Bearish John Hussman Sold Heavily in the First Quarter; New Portfolio Update May 02 2012 


    More From Other Websites
    Why Biogen Idec (BIIB) Stock Is Gaining Today Aug 18 2014
    Biogen Idec: Drug Approval Offers 'Underappreciated Earnings Upside," Morgan Stanley Says Aug 18 2014
    [video] Cramer: Market about Russia-Ukraine Aug 18 2014
    12:50 am Biogen Idec's PLEGRIDY approved in the US for the treatment of multiple sclerosis Aug 17 2014
    FDA approves Biogen's MS drug Plegridy Aug 15 2014
    FDA approves Biogen's MS drug Plegridy Aug 15 2014
    Biogen wins U.S. approval of long acting multiple sclerosis drug Aug 15 2014
    FDA approves Biogen Idec's multiple sclerosis drug Aug 15 2014
    Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple... Aug 15 2014
    Today's Momo Momentum Stock Is Biogen Idec (BIIB) Aug 15 2014
    [video] ALS stunned by millions of dollars Aug 15 2014
    [video] What is ALS? Aug 15 2014
    Perrigo Regains Some Lost Ground On Fiscal Q4 Beat Aug 14 2014
    Perrigo Beats on Q4 Earnings and Sales, Provides Guidance Aug 14 2014
    Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks Aug 14 2014
    Perrigo Q4 Beats Estimates, But Guidance Misses Aug 14 2014
    Stocks close higher for the third time in four days on tech boost Aug 13 2014
    [video] CNBC ice bucket brigade Aug 13 2014
    Top Large-Cap Growth Fund Owns Biogen, Facebook Aug 12 2014
    [video] Costolo accepts CNBC's ice bucket challenge Aug 12 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide